Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Drops(Beijing Haiyi Pharma)

氨溴特罗口服滴剂(北京海一药业)

Report date: 2025/08/27 15:30:08

Base Information

Drug NameAmbroxol Hydrochloride and Clenbuterol Hydrochloride Oral Drops(Beijing Haiyi Pharma)
Drug Alias Name氨溴特罗氨溴特罗口服滴剂(2.2类改良型)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsSodium channel alpha subunitBeta-2 adrenergic receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusIND
Highest Status in ChinaIND
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A